Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Nab-paclitaxel

3 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCBRE1706

    02/08/2018

    A Phase III Randomized Study to Investigate the Efficacy and Safety of Atezolizumab (Anti-PDL-1 Antibody) in Combination with Neoadjuvant Anthracycline/Nab-Paclitaxel-Based Chemotherapy Compared with Placebo and Chemotherapy in Patients with Primary Invasive Triple-Negative Breast Cancer

    Treatment

    VICCMD1710

    08/03/2017

    A Phase 1/2, Open-Label, Dose-Escalation, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination with a PD-1 Inhibitor and Chemotherapy in Subjects with Advanced or Metastatic Solid Tumors (ECHO-207)

    Treatment

    VICCHEMP1558

    10/09/2015

    A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB052793 in Subjects With Advanced Malignancies


    Print this page for your doctor